These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11534486)

  • 41. [Fibrinolytic therapy for ST-elevation myocardial infarction].
    Obayashi T
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():420-4. PubMed ID: 22519026
    [No Abstract]   [Full Text] [Related]  

  • 42. [Which therapy in the acute stage of myocardial infarct is in position to prolong survival?].
    Colombo ML; Specchia G
    Minerva Cardioangiol; 1988 Oct; 36(10):473-81. PubMed ID: 2906411
    [No Abstract]   [Full Text] [Related]  

  • 43. Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough?
    Mrdovic IB
    Eur Heart J; 2006 Jan; 27(1):118-9; author reply 119. PubMed ID: 16272212
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cutaneous and ophthalmic side effects of practolol].
    Okrasiński H
    Przegl Dermatol; 1976; 63(6):837-40. PubMed ID: 1005770
    [No Abstract]   [Full Text] [Related]  

  • 45. [Oculocutaneous reactions following treatment with betablockers].
    Erikssen J
    Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1288-9. PubMed ID: 9706
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter: Ocular reactions to beta-blockers.
    Lyall JR
    Br Med J; 1975 Jun; 2(5973):747. PubMed ID: 237597
    [No Abstract]   [Full Text] [Related]  

  • 47. [Review: beta-blocking agents in dermatology (author's transl)].
    Clerens A; Guilmot-Bruneau MM; Defresne C; Bourlond A
    Dermatologica; 1981; 163(1):5-11. PubMed ID: 6115777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmacotherapy after cardiac infarction].
    Darius H; Meyer J
    Internist (Berl); 2001 May; 42(5):699-712. PubMed ID: 11400577
    [No Abstract]   [Full Text] [Related]  

  • 49. [Thrombolysis and intravenous beta-blockaders in the acute phase of myocardial infarction].
    Jarry G; Hermida JS; Rey JL; Avinée P; Quiret JC; Bernasconi P
    Ann Cardiol Angeiol (Paris); 1990 Feb; 39(2):83-8. PubMed ID: 1970468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ocular complications following practolol administration].
    Wolter-Czerwińska H; Filipowicz-Banachowa AF
    Klin Oczna; 1976; 46(10):1103-6. PubMed ID: 979060
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
    Tomov I
    Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: Skin reactions to beta-blockers.
    Br Med J; 1975 Mar; 1(5958):626. PubMed ID: 236068
    [No Abstract]   [Full Text] [Related]  

  • 53. [Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
    Fanchamps A
    Nouv Presse Med; 1978 Sep; 7(31):2741-5. PubMed ID: 30954
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations.
    Thomas M
    Acta Med Scand Suppl; 1976; 587():185-91. PubMed ID: 3097
    [No Abstract]   [Full Text] [Related]  

  • 55. [Drug eruptions caused by beta-blockers].
    Bonnetblanc JM
    Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug-induced localized systemic scleroses.
    Graham JR
    Trans Am Clin Climatol Assoc; 1981; 92():122-32. PubMed ID: 6116306
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term ischemic risks after successful thrombolysis for acute myocardial infarction.
    Rackley CE
    J Am Coll Cardiol; 1989 Dec; 14(7):1616-7. PubMed ID: 2584548
    [No Abstract]   [Full Text] [Related]  

  • 60. Beta-adrenoceptor blocking drugs and the eye.
    Vogel R
    J Clin Hosp Pharm; 1983 Jun; 8(2):209-18. PubMed ID: 6135719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.